Gilbert & Cook, Inc.
- SEC CIK
- 0001675762
- Latest filing
- Jul 28, 2026
PFE holding history
Pfizer Inc in every 13F filed by Gilbert & Cook, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 26,539
- Value
- $639.1K
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 26,539 | $639.1K | 0.1% | +314+1.2% | Added | Holders |
| Q1 2026 | 26,225 | $736.4K | 0.1% | +677+2.6% | Added | Holders |
| Q4 2025 | 25,548 | $636.1K | 0.1% | +257+1.0% | Added | Holders |
| Q3 2025 | 25,291 | $644.4K | 0.1% | +572+2.3% | Added | Holders |
| Q2 2025 | 24,719 | $599.2K | 0.1% | +323+1.3% | Added | Holders |
| Q1 2025 | 24,396 | $618.2K | 0.1% | −1,297−5.0% | Reduced | Holders |
| Q4 2024 | 25,693 | $681.6K | 0.1% | +450+1.8% | Added | Holders |
| Q3 2024 | 25,243 | $730.5K | 0.1% | +700+2.9% | Added | Holders |
| Q2 2024 | 24,543 | $686.7K | 0.1% | −1,948−7.4% | Reduced | Holders |
| Q1 2024 | 26,491 | $735.1K | 0.1% | +840+3.3% | Added | Holders |
| Q4 2023 | 25,651 | $738.5K | 0.1% | +945+3.8% | Added | Holders |
| Q3 2023 | 24,706 | $819.5K | 0.1% | +1,915+8.4% | Added | Holders |
| Q2 2023 | 22,791 | $836.0K | 0.1% | +1,523+7.2% | Added | Holders |
| Q1 2023 | 21,268 | $867.7K | 0.1% | +283+1.3% | Added | Holders |
| Q4 2022 | 20,985 | $1.08M | 0.2% | +300+1.5% | Added | Holders |
| Q3 2022 | 20,685 | $974.0K | 0.2% | +303+1.5% | Added | Holders |
| Q2 2022 | 20,382 | $1.07M | 0.2% | +301+1.5% | Added | Holders |
| Q1 2022 | 20,081 | $1.04M | 0.2% | +2,750+15.9% | Added | Holders |
| Q4 2021 | 17,331 | $1.02M | 0.2% | +560+3.3% | Added | Holders |
| Q3 2021 | 16,771 | $721.0K | 0.1% | +739+4.6% | Added | Holders |
| Q2 2021 | 16,032 | $628.0K | 0.1% | +864+5.7% | Added | Holders |
| Q1 2021 | 15,168 | $550.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.